Cargando…
Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis
To compare clinical curative effects and toxicity of recombinant human adenovirus-p53 injection (rAd-p53, Gendicine) combining chemoradiotherapy (CRT)/radiotherapy (RT) with those obtained with CRT/RT alone in nasopharyngeal carcinoma (NPC). We searched all the eligible studies from the Pubmed, Coch...
Autores principales: | Yuan, Cheng, Xu, Xin-Hua, Chen, Zhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083707/ https://www.ncbi.nlm.nih.gov/pubmed/27843742 http://dx.doi.org/10.1186/s40064-016-3574-6 |
Ejemplares similares
-
Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis
por: Guo, Yaru, et al.
Publicado: (2021) -
Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis
por: Liu, Yehong, et al.
Publicado: (2016) -
Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review
por: Hosmani, Jagadish, et al.
Publicado: (2021) -
Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer
por: Qu, Juan, et al.
Publicado: (2020) -
Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma
por: Chen, Zhuo, et al.
Publicado: (2015)